Preoperative arterial embolization of hepatocellular carcinoma using DC beads; embolization and resect study

Preoperative arterial embolization of hepatocellular carcinoma using DC beads; embolization and resect study - Preoperative arterial embolization of hepatocellular carcinoma using DC beads; embolization and resect study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014607

Enrollment

Registered

2014-08-27

Start date

2014-09-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

transarterial embolization

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1) No will of hepatic resection 2) No adaptation of hepatic resection. 3) No adaptation of hepatic arterialembolization. 4) Under 20 years old. 5) Patients have severe comorbidities as follows: a:uncontrolled malignant tumor b:sever lung complications c:sever heart failure d:sever liver disease e:sever active inflammation or infection f:poor control diabetes g:Immunocompromised state including the whole steroid therapy. h:Case having complications considered to disturb completion of thehepatic resection 6) Past history of radiation exposure to the lesion. 7) Tumor thrombus reached to main portal trunk. 8) Having bleeding tendency. 9) Anticoagulant therapy cannot be interrupted. 10) In pregnant or suspected to pregnant. 11) Judged as not suitable for this clinical study by attending doctor.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of transarterial embolization of HCC using DC beads.	—

Countries

Japan

Contacts

Public ContactHiroyasu Fujiwara

Okayama University Hospital Radiology

hirofujiwar@gmail.com086-235-7313

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026